Home

Beta interferon appeals flood in

2000-08-31T00:00:00

The National Institute for Clinical Excellence has received eight appeals against its decision on the use of beta interferon in the treatment of multiple sclerosis.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here